Given the link between plaque inflammation and plaque rupture (34), it is plausible that there might be an early reduction in MI incidence following anti-TNFα treatment, while potential effects on heart failure, if any, may only be noticeable over a longer time period. This evidence concerns the gene TNF and heart failure.